[go: up one dir, main page]

FI972821L - Geneettisesti ohjatun solukuoleman geenit ja proteiinit - Google Patents

Geneettisesti ohjatun solukuoleman geenit ja proteiinit Download PDF

Info

Publication number
FI972821L
FI972821L FI972821A FI972821A FI972821L FI 972821 L FI972821 L FI 972821L FI 972821 A FI972821 A FI 972821A FI 972821 A FI972821 A FI 972821A FI 972821 L FI972821 L FI 972821L
Authority
FI
Finland
Prior art keywords
genes
proteins
cell death
controlled cell
genetically controlled
Prior art date
Application number
FI972821A
Other languages
English (en)
Swedish (sv)
Other versions
FI972821A0 (fi
FI972821A7 (fi
Inventor
Junying Yuan
Masayuki Miura
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of FI972821A0 publication Critical patent/FI972821A0/fi
Publication of FI972821L publication Critical patent/FI972821L/fi
Publication of FI972821A7 publication Critical patent/FI972821A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B75/00—Other engines
    • F02B75/02—Engines characterised by their cycles, e.g. six-stroke
    • F02B2075/022—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle
    • F02B2075/027—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle four

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI972821A 1995-01-04 1996-01-04 Geneettisesti ohjatun solukuoleman geenit ja proteiinit FI972821A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/368,704 US6087160A (en) 1993-06-24 1995-01-04 Programmed cell death genes and proteins
PCT/US1996/000177 WO1996020721A1 (en) 1995-01-04 1996-01-04 Programmed cell death genes and proteins

Publications (3)

Publication Number Publication Date
FI972821A0 FI972821A0 (fi) 1997-06-30
FI972821L true FI972821L (fi) 1997-09-03
FI972821A7 FI972821A7 (fi) 1997-09-03

Family

ID=23452396

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972821A FI972821A7 (fi) 1995-01-04 1996-01-04 Geneettisesti ohjatun solukuoleman geenit ja proteiinit

Country Status (10)

Country Link
US (2) US6087160A (fi)
EP (1) EP0808169A4 (fi)
JP (1) JPH11500304A (fi)
AU (1) AU4747296A (fi)
CA (1) CA2209526A1 (fi)
FI (1) FI972821A7 (fi)
IL (1) IL116671A0 (fi)
MX (1) MX9705039A (fi)
NO (1) NO973107L (fi)
WO (1) WO1996020721A1 (fi)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993025685A1 (en) * 1992-06-12 1993-12-23 Massachusetts Institute Of Technology Cloning and characterization of the cell death genes ced-3 and ced-4
US7097972B1 (en) 1995-02-13 2006-08-29 Regents Of The University Of Michigan Method and composition for regulating apoptosis
US6015665A (en) * 1995-02-13 2000-01-18 The Regents Of The University Of Michigan Method and composition for regulating apoptosis
US6060238A (en) * 1995-02-13 2000-05-09 The Regents Of The University Of Michigan Method and composition for regulating apoptosis
US6747138B1 (en) 1995-04-03 2004-06-08 Regents Of The University Of Michigan Methods and compositions for regulating Fas-associated apoptosis
US7807783B1 (en) 1995-04-03 2010-10-05 The Regents Of The University Of Michigan Methods and compositions for regulating FAS-associated apoptosis
US6214572B1 (en) * 1996-08-09 2001-04-10 The General Hospital Corporation Programmed cell death and ICH-3
US5897992A (en) * 1996-09-27 1999-04-27 Cold Spring Harbor Laboratory Cell-free assay using oncogene-induced apoptosis in drug-resistant cells
US6342611B1 (en) 1997-10-10 2002-01-29 Cytovia, Inc. Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof
US6184210B1 (en) 1997-10-10 2001-02-06 Cytovia, Inc. Dipeptide apoptosis inhibitors and the use thereof
DE69925268T2 (de) * 1998-03-16 2006-03-23 Cytovia, Inc., San Diego Dipeptid-Caspase-Inhibitoren und deren Verwendung
WO1999052925A1 (en) * 1998-04-16 1999-10-21 The General Hospital Corporation Programmed cell death and caspase-12
DE69920473T2 (de) 1998-07-21 2006-02-23 Cytovia, Inc., San Diego Neue fluoreszenzfarbstoffe und ihre anwendung in fluoreszenznachweisverfahren ganzer zellen für kaspasen, peptidasen, proteasen und andere enzyme sowie deren verwendung
KR20010110667A (ko) 1999-03-16 2001-12-13 추후보정 치환 2-아미노벤즈아미드 카스파제 저해제 및 그것의 용도
AU4213500A (en) 1999-04-09 2000-11-14 Cytovia, Inc. Caspase inhibitors and the use thereof
US6462041B1 (en) 1999-05-21 2002-10-08 Cytovia, Inc. Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosis
WO2001016093A1 (en) 1999-08-27 2001-03-08 Cytovia, Inc. SUBSTITUTED α-HYDROXY ACID CASPASE INHIBITORS AND THE USE THEREOF
US6566338B1 (en) 1999-10-12 2003-05-20 Cytovia, Inc. Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death
CA2390164C (en) 1999-11-05 2011-03-29 Cytovia, Inc. Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof
US7053117B2 (en) 2001-05-16 2006-05-30 Cytovia, Inc. Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
CA2397493A1 (en) 2000-01-27 2001-08-02 Cytovia, Inc. Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
US6861419B2 (en) 2000-04-18 2005-03-01 Cytovia, Inc. Substituted 1, 4-thiazepine and analogs as activators of caspases and inducers of apoptosis and the use thereof
US7569351B2 (en) * 2000-08-03 2009-08-04 Oncotherapy Science, Inc. P53 dependent apoptosis-associated gene and protein
WO2002012545A2 (en) 2000-08-03 2002-02-14 Cytovia, Inc. Method of identifying immunosuppressive agents
AU2001289068A1 (en) * 2000-09-20 2002-04-02 Isis Pharmaceuticals, Inc. Antisense modulation of caspase 2 expression
US6716851B2 (en) 2000-12-12 2004-04-06 Cytovia, Inc. Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators or caspases and inducers of apoptosis and the use thereof
EP1399159A4 (en) 2001-06-01 2007-02-14 Cytovia Inc 4-SUBSTITUTED 1- (ARYLMETHYLIDEN) THIOSEMICARBAZIDE, 4-SUBSTITUTED 1- (ARYLCARBONYL) THIOSEMICARBAZIDE AND ANALOGUES AS ACTIVATORS OF CASPASES AND APOPTOSIS INDUCTORS AND THEIR USE
US7041685B2 (en) 2001-06-08 2006-05-09 Cytovia, Inc. Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
US7476741B2 (en) 2002-05-16 2009-01-13 Cytovia, Inc. Substituted 4H-chromens, 2H-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereof
WO2003097806A2 (en) 2002-05-16 2003-11-27 Cytovia, Inc. Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
CN100364531C (zh) 2002-12-18 2008-01-30 西托维亚公司 3,5－二取代－[1,2,4]－二唑及类似物和其用途
AU2004253967B2 (en) 2003-07-03 2010-02-18 Cytovia, Inc. 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
CN1954882A (zh) * 2005-10-14 2007-05-02 李海 长效人重组可溶性肿瘤坏死因子α受体在制备防治肝衰竭药物中的用途
WO2016040517A1 (en) 2014-09-09 2016-03-17 Merial Inc. Mammalian cell lines expressing functional nematode acetylcholine receptors and use thereof for high-throughput screening assays

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015577A1 (en) * 1990-04-04 1991-10-17 Black, Roy, A. INTERLEUKIN 1'beta' PROTEASE
DE69229252T2 (de) * 1991-08-16 1999-12-16 Merck & Co., Inc. DNS, welche das Interleukin-1B-Vorläufer-Converting-Enzym kodiert
AU657701B2 (en) * 1991-08-30 1995-03-23 Vertex Pharmaceuticals Incorporated Interleukin 1beta protease and interleukin 1beta protease inhibitors
GB9124986D0 (en) * 1991-11-25 1992-01-22 Greenberg Arnold H Natural killer cell granule protein
JPH08500482A (ja) * 1992-06-12 1996-01-23 マサチューセッツ インスティテュート オブ テクノロジー Ｃｅｄ−３及び関連蛋白質のインヒビター
WO1993025685A1 (en) * 1992-06-12 1993-12-23 Massachusetts Institute Of Technology Cloning and characterization of the cell death genes ced-3 and ced-4
EP0711174A4 (en) * 1993-06-24 1997-11-12 Gen Hospital Corp GENES FOR PROGRAMMED CELL DEATH AND PROTEINS
WO1996000297A1 (en) * 1994-06-23 1996-01-04 Human Genome Sciences, Inc. INTERLEUKIN-1 β CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-1 AND 2

Also Published As

Publication number Publication date
MX9705039A (es) 1997-10-31
NO973107D0 (no) 1997-07-03
EP0808169A1 (en) 1997-11-26
US6087160A (en) 2000-07-11
US20030124105A1 (en) 2003-07-03
WO1996020721A1 (en) 1996-07-11
JPH11500304A (ja) 1999-01-12
NO973107L (no) 1997-08-26
EP0808169A4 (en) 2002-09-11
IL116671A0 (en) 1996-05-14
AU4747296A (en) 1996-07-24
FI972821A0 (fi) 1997-06-30
FI972821A7 (fi) 1997-09-03
CA2209526A1 (en) 1996-07-11

Similar Documents

Publication Publication Date Title
FI972821L (fi) Geneettisesti ohjatun solukuoleman geenit ja proteiinit
EP0711174A4 (en) GENES FOR PROGRAMMED CELL DEATH AND PROTEINS
NZ263025A (en) Development genes and proteins from plants homologous to mammalian qm genes and their use
NO943344D0 (no) MN-gen og -protein
FI953569L (fi) Neuraalisten kantasolujen geneettinen modifikaatio
FI960331L (fi) Gandida utilis -hiivan transformointisysteemit ja vieraiden geenien ilmentäminen niiden avulla
DE69433168D1 (de) In vitro vermehrung von stammzellen
FI963513A7 (fi) Geenien rinnakkainen ilmentäminen in vivo
EE9900357A (et) Geenisekvenaator ja meetodid
FI953812A7 (fi) Kohdistettujen geenien säädelty transkriptio ja muita biologisia toimintoja
EP0852627A4 (en) CELL DEATH PROTEIN
FI935485A7 (fi) PEG-hydratsoni- ja PEG-oksiimisidoksen muodostavat reagenssit ja niiden proteiinijohdannaiset
AU6687696A (en) Transgenic swine and swine cells having human hla genes
FI952022L (fi) Biologiset tekijät ja neuraaliset kantasolut
FI864331A7 (fi) Transformaatio ja vieraiden geenien ilmaiseminen puulajeilla.
DK299087D0 (da) Proteins and derivatives thereof
FI954602A7 (fi) Koostumukset ja menetelmät käyttää ehdollisesti letaaleja geenejä
NO964758D0 (no) Anvendelse av von Willebrand-faktor og farmasöytiske preparater
PL337942A1 (en) Isolated genes of dendricall cell membranic proteins
DE69131381D1 (de) Strukturproteine durch künstliche gene
GB9516059D0 (en) Novel genes and proteins
EP0774510A4 (en) EGG CELLS
FI903716A7 (fi) Ksantaanikumin asetylaation ja pyruvylaation geneettinen säätely
DK61486D0 (da) Gener for biologisk aktive proteiner
DE59605796D1 (de) Oximether- und acrylsäurederivate und ihre verwendung als fungizide